Ardelyx Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Ardelyx Inc.
- Former names
- Nteryx Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Fremont
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ARDX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001437402
Board of directors
-
David M. Mott · DirectorSince 2023
-
Geoffrey A. Block · DirectorSince 2023
-
Jan M. Lundberg · DirectorSince 2023
-
Merdad Parsey · DirectorSince 2025
-
Michael Raab · Director · President & CEOSince 2023
-
Muna Bhanji · DirectorSince 2023
-
Onaiza Cadoret-Manier · DirectorSince 2023
-
Richard J. Rodgers · DirectorSince 2023
-
Robert B. Bazemore · DirectorSince 2023
-
William C. Bertrand Jr. · DirectorSince 2023
Chief executives
Michael Raab
· President & CEO
Dates unknown
Director election results
Annual meeting of June 16, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.7%
-
96.9%
Board connections
6 of this board's directors also sit on 10 other boards.
- via David M. Mott and Richard J. Rodgers
- via Merdad Parsey and Richard J. Rodgers
- via Robert B. Bazemore
- via Merdad Parsey
- via Muna Bhanji
- via Muna Bhanji
- via Robert B. Bazemore
- via Richard J. Rodgers
- via Michael Raab
- via Muna Bhanji
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,946,665
- 1 purchase by 1 insider
- Sold, last 12 months
- $4,303,641
- 78 sales by 9 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 21, 2026 | Bishop John E Officer (See Remarks) | Open-market sale | −17,281 | $3.86 | $66,651 |
| Aug 21, 2026 | Michael Raab Director, Officer (President & CEO) | Open-market sale | −15,009 | $3.86 | $57,888 |
| Aug 21, 2026 | Williams Laura A Officer (Chief Patient Officer) | Open-market sale | −3,486 | $3.86 | $13,445 |
| Aug 21, 2026 | Mike Kelliher Officer (Chief Business Officer) | Open-market sale | −3,104 | $3.86 | $11,972 |
| Aug 21, 2026 | Foster Eric Duane Officer (Chief Commercial Officer) | Open-market sale | −2,598 | $3.86 | $10,020 |
| Aug 21, 2026 | Reilly Joseph James Officer (See Remarks) | Open-market sale | −2,872 | $3.86 | $11,077 |
| Aug 21, 2026 | Brady James Parker Officer (Chief Human Resources Officer) | Open-market sale | −1,976 | $3.86 | $7,621 |
| Aug 21, 2026 | Hohenleitner Susan Officer (Chief Financial Officer) | Open-market sale | −1,558 | $3.86 | $6,009 |
| Aug 21, 2026 | Bishop John E Officer (See Remarks) | Open-market sale | −2,469 | $3.86 | $9,523 |
| Aug 21, 2026 | Michael Raab Director, Officer (President & CEO) | Open-market sale | −15,976 | $3.86 | $61,618 |
| Aug 21, 2026 | Williams Laura A Officer (Chief Patient Officer) | Open-market sale | −3,089 | $3.86 | $11,914 |
| Aug 21, 2026 | Mike Kelliher Officer (Chief Business Officer) | Open-market sale | −2,652 | $3.86 | $10,229 |
| Aug 21, 2026 | Foster Eric Duane Officer (Chief Commercial Officer) | Open-market sale | −3,389 | $3.86 | $13,071 |
| Aug 21, 2026 | Reilly Joseph James Officer (See Remarks) | Open-market sale | −1,110 | $3.86 | $4,281 |
| Aug 21, 2026 | Brady James Parker Officer (Chief Human Resources Officer) | Open-market sale | −13,160 | $3.86 | $50,757 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.